Fidelity European Trust July summary – financial stocks drive gains

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for the period ended July 2023.

Portfolio Manager Commentary
Continental European equities continued to advance in July on cooling inflation in the eurozone and the US, and the announcement of additional stimulus measures in China. Both the European Central Bank (ECB) and the US Federal Reserve raised interest rates by 0.25 percentage points, as widely expected by
markets. ECB’s overall tone moved in a dovish direction, with the bank expecting inflation to drop further over the remainder of the year. The eurozone economy grew modestly during the second quarter with preliminary estimates showing that GDP expanded by 0.3%, contributing to the perception of a soft-landing scenario.

During the month, the Trust recorded positive returns but underperformed the index. Security selection in industrials, health care and technology detracted from relative returns. However, strong performance of financials stocks drove gains. At a stock level, MTU Aero Engines was negatively impacted by the recall of
GTF engines due to metal contamination issues. Positively, MTU reported in line Q2 results. Among the key contributors, private equity company Partners Group rallied after reiterating AUM guidance for the full year.

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and
share price returns of 17.4% and 23.5% respectively, compared to 16.1% for the index.

Fidelity European Trust PLC (LON:FEV) is a European investment trust. It  aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers.

Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance.

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

Search

Search